written on 06.03.2014

Tax rise mitigates Japan price cut but DPP-4s hit hard


The next regular biennial revision of drug reimbursement prices in Japan will see levels cut by an average of 2.65% across the board on 1 April, including the mitigating effect of an increase in the general consumption tax at the same time.